In accordance with the data in glioma cells with CD147 knockdown, CD147 overexpression increased cell growth rate and the resistance to TMZ treatment, and decreased TMZ induced ROS production, dose-dependently (Figure 2G-2K). Here, BSG is linked to glioma.